Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

AMGLIDIA 0,6 mg/ml SUSPENSION ORAL - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/AMGLIDIA 0,6 mg/ml SUSPENSION ORAL

Approved

STANDARD

AMGLIDIA 0,6 mg/ml SUSPENSION ORAL

Ammtek🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jan 14, 2021
Approval ID: d7910680fd6c8a00
Company: Ammtek
Type: Standard

Approval Details

Approval Id: d7910680fd6c8a00
Drug Cima Aemps Name: AMGLIDIA 0,6 mg/ml SUSPENSION ORAL
Register Number: 1181279001
Holder Company Name: Ammtek
Marketing Company Name: Bioprojet Pharma
Holder Company Detail Path: /organization/ammtek-ltd
Marketing Company Detail Path: /organization/bioprojet-pharma
Authorization Date: 2021-01-14
Dosage Form: SUSPENSIÓN ORAL
Dose: 0,6 mg/ml
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: No
Company Name: Ammtek
Company Detail Path: /organization/ammtek-ltd

Company Information

Pharmaceutical Company Name: Ammtek Ltd.

Active Ingredients

GLIBENCLAMIDA

18 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jan 14, 2021

Approval ID

d7910680fd6c8a00

Type

Standard

Back to CIMA-AEMPS Approvals